| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029240 |
| Receipt No. | R000033425 |
| Scientific Title | Dermato-pharmacokinetic study of single application of lanoconazole |
| Date of disclosure of the study information | 2017/10/01 |
| Last modified on | 2020/03/25 (Ver. 4) |
| Basic information | ||
| Public title | Dermato-pharmacokinetic study of single application of lanoconazole | |
| Acronym | Dermato-pharmacokinetic study of single application of lanoconazole | |
| Scientific Title | Dermato-pharmacokinetic study of single application of lanoconazole | |
| Scientific Title:Acronym | Dermato-pharmacokinetic study of single application of lanoconazole | |
| Region |
|
|
| Condition | ||
| Condition | healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the pharmacokinetics of lanoconazole in human dermis after single application |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | pharmacokinetic parameters of lanoconazole in stratum corneum
(time of assessment: within 3 months after completion of drug administration) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | external administration of lanoconazole | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | BMI >=17.5, <30.0 | |||
| Key exclusion criteria | *any skin abnormality
*any drug, cosmetics, or food allergy *any abnormal findings in the following items, hematology, biochemistry, urinalysis, blood pressure, ECG, and clinical examination |
|||
| Target sample size | 6 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Oita University Faculty of Medicine | ||||||
| Division name | Dept of Medical Ethics | ||||||
| Zip code | 8795593 | ||||||
| Address | 1-1 Idaigaoka, Hasama, Yufu, Oita, JAPAN | ||||||
| TEL | 097-586-5952 | ||||||
| imaih@oita-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Oita University Faculty of Medicine | ||||||
| Division name | Dept of Medical Ethics | ||||||
| Zip code | 8795593 | ||||||
| Address | 1-1 Idaigaoka, Hasama, Yufu, Oita, JAPAN | ||||||
| TEL | 097-586-5952 | ||||||
| Homepage URL | |||||||
| imaih@oita-u.ac.jp | |||||||
| Sponsor | |
| Institute | Oita University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Maruho pharmaceutical company |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board, Oita University Hospital |
| Address | 1-1 Idaigaoka, Hasama, Yufu, Oita, JAPAN |
| Tel | 097-586-6163 |
| gcrcjimu@oita-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033425 |